Cleared Traditional

K111922 - VOCARE MYHEALTH TABLET

K111922 is an FDA 510(k) clearance for VOCARE MYHEALTH TABLET, manufactured by Vocare, Inc.. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K111922 · Vocare, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
149d
Days
Class 2
Risk

K111922 is an FDA 510(k) clearance for the VOCARE MYHEALTH TABLET. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Vocare, Inc. (Indianapolis, US). The FDA issued a Cleared decision on December 2, 2011 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vocare, Inc. devices

FDA 510(k) Submission Details - K111922

510(k) Number K111922 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2011
Decision Date December 02, 2011
Days to Decision 149 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 125d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 178
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K111922.
3M LITTMANN TELESTETH ONLINE AUSCULATION SYSTEM
K120704 · 3M Company · May 2012
GENESIS TOUCH SYSTEM
K112858 · Honeywell Hommed, LLC · Jan 2012
TCX-I REMOTE CARE MANAGEMENT SYSTEM
K113493 · Bl Healthcare, Inc. · Dec 2011
MEDAPPS 2.0 REMOTE PATIENT MONITORING SYSTEM
K112559 · Medapps, Inc. · Dec 2011
AO USB RECEIVER, WI-BOX, WI-BOX PSU KIT, WI-BOX XPRESS CABLE, PW USB RECEIVER
K111854 · St. Jude Medical Systems AB · Oct 2011
ASCOT HOME MEDICAL MONITORING SYSTEM (HMMS)
K103643 · Ascot Technologies, Inc. · Oct 2011